biphasic human insulin 30: Clinical Trials

4 trials of biphasic human insulin 30, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow biphasic human insulin 30: new trials by email Literature Review of biphasic human insulin 30 trials Research Report on biphasic human insulin 30

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
biphasic insulin aspart, biphasic human insulin - Diabetes, Diabetes Mellitus, Type 2
Phase 3CompletedNovo Nordisk A/S812007-04-012023-11-02
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes
biphasic insulin aspart, biphasic human insulin - Diabetes, Diabetes Mellitus, Type 1
Phase 3CompletedNovo Nordisk A/S2192003-07-082017-02-24
Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes
biphasic insulin aspart 50, biphasic insulin aspart 70, biphasic human insulin 30 - Diabetes, Diabetes Mellitus, Type 1
Phase 3CompletedNovo Nordisk A/S6662000-03-012017-01-04
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
biphasic insulin aspart, biphasic human insulin - Diabetes, Diabetes Mellitus, Type 1
Phase 3CompletedNovo Nordisk A/S3031998-04-012017-01-04

Conditions studied

Diabetes Mellitus (4)  ·  Diabetes Mellitus, Type 2 (4)  ·  Diabetes Mellitus, Type 1 (3)

Sponsors

Novo Nordisk A/S (4)

Countries

Ireland (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Belgium (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Switzerland (1)

Results publications

PMID 11978684, PMID 12027927, PMID 18269638